Blurring lines of advice, advertising

June 13, 2007

Caremark, a company that manages prescription drug insurance plans, has accepted payments from a pharmaceutical maker to produce newsletters that appear to promote one of its medications – a practice that has raised questions of conflicts of interest. (Newsday)